Upgrade to SI Premium - Free Trial

Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance

October 30, 2014 4:27 PM

Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.

Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.

For earnings history and earnings-related data on Chemed (CHE) click here.

Categories

Earnings Guidance